Abstract
Myeloid sarcoma (MS) represents a rare disease with an adverse clinical outcome for patients not candidate to acute myeloid leukemia (AML)-like chemotherapies. Here we present the case of an elderly patient affected by a bilateral breast localization of MS treated with the hypomethylating agent decitabine associated to radiotherapy. The association of the two treatment modalities has allowed an optimal and long-lasting disease control.
Original language | English |
---|---|
Article number | 84 |
Journal | Diagnostics |
Volume | 9 |
Issue number | 3 |
DOIs | |
Publication status | Published - Sep 1 2019 |
Keywords
- Acute myeloid
- Breast
- Decitabine
- Extramedullary
- Leukemia
- Myeloid
- Sarcoma
ASJC Scopus subject areas
- Clinical Biochemistry